Britt Meelby Jensen

Britt Meelby Jensen is an accomplished executive with extensive experience in the healthcare and pharmaceuticals sectors. Currently serving as Chief Executive Officer and Member of the Board at Ambu A/S since 2019, Britt also holds board positions at Novo Holdings and the Hempel Foundation. Previous leadership roles include CEO of Atos Medical and President and CEO of Zealand Pharma A/S. Furthermore, Britt has held various senior marketing roles at Novo Nordisk, including Corporate Vice President. With an academic background that includes an M.Sc. in International Marketing & Management from Copenhagen Business School and an MBA in Economics from Solvay Brussels School of Economics and Management, Britt has a strong foundation in both business strategy and marketing.